Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DNAP001389

Drug Information
NameHuman neutral insulin
Trade NameNovolin r
IndicationAntidiabeticApproved    
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C257H383N65O77S6/c1-29-131(23)205(313-193(339)104-259)252(393)
317-204(130(21)22)248(389)288-159(75-82-200(349)350)217(358)282-1
56(71-78-189(263)335)221(362)308-183-116-403-404-117-184-243(384)
305-178(111-324)240(381)294-162(88-123(7)8)225(366)295-168(95-140
-53-61-146(329)62-54-140)228(369)283-154(69-76-187(261)333)218(35
9)290-161(87-122(5)6)223(364)285-158(74-81-199(347)348)220(361)30
2-174(101-190(264)336)235(376)298-170(97-142-57-65-148(331)66-58-
142)231(372)309-182(242(383)304-176(255(396)397)103-192(266)338)1
15-402-401-114-181(214(355)273-107-194(340)278-153(72-79-197(343)
344)216(357)281-151(51-42-84-271-257(267)268)212(353)272-108-195(
341)279-166(93-138-46-36-32-37-47-138)227(368)297-167(94-139-48-3
8-33-39-49-139)230(371)299-171(98-143-59-67-149(332)68-60-143)238
(379)320-208(135(27)327)254(395)322-85-43-52-186(322)246(387)286-
152(50-40-41-83-258)222(363)321-209(136(28)328)256(398)399)311-25
0(391)203(129(19)20)316-236(377)164(90-125(11)12)292-229(370)169(
96-141-55-63-147(330)64-56-141)296-224(365)160(86-121(3)4)289-210
(351)133(25)277-215(356)157(73-80-198(345)346)287-247(388)202(128
(17)18)315-237(378)165(91-126(13)14)293-233(374)173(100-145-106-2
70-120-276-145)301-239(380)177(110-323)280-196(342)109-274-213(35
4)180(113-400-405-118-185(310-244(183)385)245(386)319-207(134(26)
326)253(394)306-179(112-325)241(382)318-206(132(24)30-2)251(392)3
12-184)307-226(367)163(89-124(9)10)291-232(373)172(99-144-105-269
-119-275-144)300-219(360)155(70-77-188(262)334)284-234(375)175(10
2-191(265)337)303-249(390)201(127(15)16)314-211(352)150(260)92-13
7-44-34-31-35-45-137/h31-39,44-49,53-68,105-106,119-136,150-186,2
01-209,323-332H,29-30,40-43,50-52,69-104,107-118,258-260H2,1-28H3
,(H2,261,333)(H2,262,334)(H2,263,335)(H2,264,336)(H2,265,337)(H2,
266,338)(H,269,275)(H,270,276)(H,272,353)(H,273,355)(H,274,354)(H
,277,356)(H,278,340)(H,279,341)(H,280,342)(H,281,357)(H,282,358)(
H,283,369)(H,284,375)(H,285,364)(H,286,387)(H,287,388)(H,288,389)
(H,289,351)(H,290,359)(H,291,373)(H,292,370)(H,293,374)(H,294,381
)(H,295,366)(H,296,365)(H,297,368)(H,298,376)(H,299,371)(H,300,36
0)(H,301,380)(H,302,361)(H,303,390)(H,304,383)(H,305,384)(H,306,3
94)(H,307,367)(H,308,362)(H,309,372)(H,310,385)(H,311,391)(H,312,
392)(H,313,339)(H,314,352)(H,315,378)(H,316,377)(H,317,393)(H,318
,382)(H,319,386)(H,320,379)(H,321,363)(H,343,344)(H,345,346)(H,34
7,348)(H,349,350)(H,396,397)(H,398,399)(H4,267,268,271)/t131-,132
-,133-,134+,135+,136+,150-,151-,152-,153-,154-,155-,156-,157-,158
-,159-,160-,161-,162-,163-,164-,165-,166-,167-,168-,169-,170-,171
-,172-,173-,174-,175-,176-,177-,178-,179-,180-,181-,182-,183-,184
-,185-,186-,201-,202-,203-,204-,205-,206-,207-,208-,209-/m0/s1
InChIKeyPBGKTOXHQIOBKM-FHFVDXKLSA-N
Canonical SMILESCCC(C)C1C(=O)NC2CSSCC(C(=O)NC(CSSCC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)
NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(NC(=O)C
(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CO)CC(C)
C)CC3=CC=C(C=C3)O)CCC(=O)N)CC(C)C)CCC(=O)O)CC(=O)N)CC4=CC=C(C=C4)O)C(=O)
NC(CC(=O)N)C(=O)O)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=
O)NC(CC5=CC=CC=C5)C(=O)NC(CC6=CC=CC=C6)C(=O)NC(CC7=CC=C(C=C7)O)C(=O)NC(C
(C)O)C(=O)N8CCCC8C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)O)C(C)C)CC(C)C)CC9=CC=
C(C=C9)O)CC(C)C)C)CCC(=O)O)C(C)C)CC(C)C)CC2=CN=CN2)CO)NC(=O)C(CC(C)C)NC
(=O)C(CC2=CN=CN2)NC(=O)C(CCC(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(C(C)C)NC(=O)C
(CC2=CC=CC=C2)N)C(=O)NC(C(=O)NC(C(=O)N1)CO)C(C)O)NC(=O)C(CCC(=O)N)NC(=O)
C(CCC(=O)O)NC(=O)C(C(C)C)NC(=O)C(C(C)CC)NC(=O)CN    
Isomeric SMILESCC[C@H](C)[C@H]1C(=O)N[C@H]2CSSC[C@@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)NCC
(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C
(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@H](NC
(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@
@H](NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)CO)CC(C)C)CC3=CC=C(C=C3)O)CCC(=O)N)
CC(C)C)CCC(=O)O)CC(=O)N)CC4=CC=C(C=C4)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)C(=
O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H]
(CC5=CC=CC=C5)C(=O)N[C@@H](CC6=CC=CC=C6)C(=O)N[C@@H](CC7=CC=C(C=C7)O)C(=
O)N[C@@H]([C@@H](C)O)C(=O)N8CCC[C@H]8C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@
@H](C)O)C(=O)O)C(C)C)CC(C)C)CC9=CC=C(C=C9)O)CC(C)C)C)CCC(=O)O)C(C)C)CC
(C)C)CC2=CN=CN2)CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H]
(CCC(=O)N)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC2=CC=CC=
C2)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CO)[C@@H](C)O)NC(=O)[C@H](CCC(=O)N)
NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)CN
CAS NumberCAS 11061-68-0
FormulaC257H383N65O77S6
PubChem Compound IDCID 16129672.
ChEBI5931;
SuperDrug ATC IDA10AB01



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543